Acta Med. 2014, 57: 119-126

https://doi.org/10.14712/18059694.2014.50

Human Plasma and Human Platelet-rich Plasma as a Substitute for Fetal Calf Serum during Long-term Cultivation of Mesenchymal Dental Pulp Stem Cells

Tereza Suchánková Kleplováa, Tomáš Soukupb, Vít Řeháčekc, Jakub Sucháneka,b

aDepartment of Dentistry, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic
bDepartment of Histology and Embryology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic
cTransfusion Department, University Hospital, Hradec Králové, Czech Republic

Received May 8, 2014
Accepted October 15, 2014

References

1. Gronthos S, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proceedings of the National Academy of Sciences 2000; 97(25): 13625–30. <https://doi.org/10.1073/pnas.240309797> <PubMed>
2. Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, et al. Stem cell properties of human dental pulp stem cells. J Dent Res 2002; 81: 531–35. <https://doi.org/10.1177/154405910208100806>
3. Laino G, d’Aquino R, Graziano A, Lanza V, Carinci F, Naro F, et al. A new population of human adult dental pulp stem cells: a useful source of living autologous fibrous bone tissue (LAB). J Bone Miner Res 2005; 20: 1394–402. <https://doi.org/10.1359/JBMR.050325>
4. Zhang W, Walboomers XF, Shi S, Fan M, Jansen JA. Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation. Tissue Eng 2006; 12: 2813–23. <https://doi.org/10.1089/ten.2006.12.2813>
5. Honn KV, Singley JA, Chavin W. Fetal bovine serum: A multivariate standard. Proc Soc Exp Biol Med 1975; 149: 344–47. <https://doi.org/10.3181/00379727-149-38804>
6. Zheng X, Baker H, Hancock WS, et al. Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs. Biotechnol Prog 2006; 22: 1294–300. <https://doi.org/10.1021/bp060121o>
7. Martin MJ, Muotri A, Gage F, et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005; 11: 228–32. <https://doi.org/10.1038/nm1181>
8. Spees JL, Gregory CA, Singh H, et al. Internalized antigen must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004; 9: 747–56. <https://doi.org/10.1016/j.ymthe.2004.02.012>
9. Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. New Engl J Med 2006; 355: 1730–35. <https://doi.org/10.1056/NEJMhpr063086>
10. Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting. Bull World Health Organ 1997; 75: 505–13.
11. Heiskanen A, Satomaa T, Tiitinen S, et al. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 2007; 25: 197–202. <https://doi.org/10.1634/stemcells.2006-0444>
12. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillator in cellular cardiomyoplasty. Int J Cardiol 2004; 95(Suppl 1): S29–S33. <https://doi.org/10.1016/S0167-5273(04)90009-5>
13. Tuschong L, Soenen SL, Blaese RM, et al. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002; 13: 1605–10. <https://doi.org/10.1089/10430340260201699>
14. Bruinink A, Tobler U, Halg M, et al. Effects of serum and serum heat-inactivation on human bone derived osteoblast progenitor cells. J Mater Sci Mater Med 2004; 15: 497–501. <https://doi.org/10.1023/B:JMSM.0000021127.62879.a1>
15. Dictus C, Tronnier V, Unterberg A, et al. Comparative analysis of in vitro conditions for rat adult neural progenitor cells. J Neurosci Methods 2007; 161: 250–58. <https://doi.org/10.1016/j.jneumeth.2006.11.012>
16. Dimarakis I, Levicar N. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 2006; 24: 1407–08. <https://doi.org/10.1634/stemcells.2005-0577>
17. Sekiya I, Larson BL, Smith JR, et al. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002; 20: 530–41. <https://doi.org/10.1634/stemcells.20-6-530>
18. Stojkovic P, Lako M, Przyborski S, et al. Human-serum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells 2005; 23: 895–902. <https://doi.org/10.1634/stemcells.2004-0326>
19. Lee U, Jeon SH, Park J, Choung P. Effect of platelet-rich plasma on dental stem cells derived from human impacted third molars. Regen Med 2011 Jan; 6(1): 67–79. <https://doi.org/10.2217/rme.10.96>
20. Chen B, Sun H, Wang H, Kong H, Chen F, Yu Q. The effects of human platelet lysate on dental pulp stem cells derived from impacted human third molars. Biomaterials 2012 Jul; 33(20): 5023–35. <https://doi.org/10.1016/j.biomaterials.2012.03.057>
21. Govindasamy V, Ronald VS, Abdullah ANB, Nathan KRG, Aziz ZACHA, Abdullah M, et al. Human platelet lysate permits scale-up of dental pulp stromal cells for clinical applications. Cytotherapy 2011 Nov; 13(10): 1221–33. <https://doi.org/10.3109/14653249.2011.602337>
22. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: e45–50. <https://doi.org/10.1016/j.tripleo.2005.07.009>
23. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: e51–5. <https://doi.org/10.1016/j.tripleo.2005.07.010>
24. Mannello F. Serum or Plasma Samples? The “Cinderella” Role of Blood Collection Procedures Preanalytical Methodological Issues Influence the Release and Activity of Circulating Matrix Metalloproteinases and Their Tissue Inhibitors, Hampering Diagnostic Trueness and Leading to Misinterpretation. Arterioscler Thromb Vasc Biol 2008; 28: 611–14. <https://doi.org/10.1161/ATVBAHA.107.159608>
25. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001; 10(4): 225–8. <https://doi.org/10.1097/00008505-200110000-00002>
26. Shahdadfar A, Tronsdal K, Haug T, et al. In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005; 23: 1357–66. <https://doi.org/10.1634/stemcells.2005-0094>
27. Stute N, Holtz K, Bubenheim M, et al. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004; 32: 1212–25. <https://doi.org/10.1016/j.exphem.2004.09.003>
28. Lin HT, Tarng YW, Chen YC, et al. Using human plasma supplemented medium to cultivated human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant Proc 2005; 37: 4504–05. <https://doi.org/10.1016/j.transproceed.2005.11.033>
29. Kobayashi T, Watanabe H, Yanagawa T, et al. Motility and growth of human bone-marrow mesenchymal stem cells during ex-vivo expansion in autologous serum. J Bone Joint Surg Br 2005; 87: 1426–33. <https://doi.org/10.1302/0301-620X.87B10.16160>
30. Mizuno N, Shiba H, Ozeki Y, et al. Human autologous serum obtained using a completely closed bag system as a substitute for fetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int 2006; 30: 521–24. <https://doi.org/10.1016/j.cellbi.2006.01.010>
31. Muller I, Kordowich S, Holzwarth C, et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 2006; 8: 437–44. <https://doi.org/10.1080/14653240600920782>
32. Hilfiker A, Kasper C, Hass R, Haverich A. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?. Langenbecks Arch Surg 2011; 396: 489–97. <https://doi.org/10.1007/s00423-011-0762-2>
33. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma’ayan A, Enikolopov GN, Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829–34 <https://doi.org/10.1038/nature09262> <PubMed>
34. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 2011; 9: 1–14 <https://doi.org/10.1186/1478-811X-9-12> <PubMed>
35. Mannello F, Gaetana AT. Concise Review: No Breakthroughs for Human Mesenchymal and Embryonic Stem Cell Culture: Conditioned Medium, Feeder Layer, or Feeder-Free; Medium with Fetal Calf Serum, Human Serum, or Enriched Plasma; Serum-Free, Serum Replacement Nonconditioned Medium, or Ad Hoc Formula? All That Glitters Is Not Gold!. Stem Cells 2007; 25(7): 1603–09. <https://doi.org/10.1634/stemcells.2007-0127>
36. Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004; 9: 747–56. <https://doi.org/10.1016/j.ymthe.2004.02.012>
37. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004; 95(Suppl 1): S29–S33. <https://doi.org/10.1016/S0167-5273(04)90009-5>
38. Hemeda H, Giebel B, Wagner W. Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy 2014; 16(2): 170–80. <https://doi.org/10.1016/j.jcyt.2013.11.004>
39. Gstraunthaler G, et al. Human Platelet Lysates Successfully Replace Fetal Bovine Serum in Adipose-Derived Adult Stem Cell Culture. Journal of Advanced Biotechnology and Bioengineering 2014; 2(1): 1–11. <https://doi.org/10.12970/2311-1755.2014.02.01.1>
40. Mojica-Henshaw MP, et al. Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures. Cytotherapy 2013; 15(12): 1458–68. <https://doi.org/10.1016/j.jcyt.2013.06.014>
41. Trojahn Kølle S-F, et al. Pooled human platelet lysate versus fetal bovine serum – investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use. Cytotherapy 2013; 15(9): 1086–97. <https://doi.org/10.1016/j.jcyt.2013.01.217>
42. Stute N, et al. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Experimental Hematology 2004; 32(12): 1212–25. <https://doi.org/10.1016/j.exphem.2004.09.003>
43. Suchanek J, et al. Dental pulp stem cells and their characterization. Biomedical Papers of the Medical Faculty of Palacky University in Olomouc 2009; 153(1): 31–35. <https://doi.org/10.5507/bp.2009.005>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Archive